Neuralink and mRNA Technologies are Weapons of Mass Destruction

Neuralink and mRNA Technologies are Weapons of Mass Destruction

Under the guise of dual-use, mRNA nanotechnology (COVID-19 vaccines) and BCI neurotechnology (Neuralink) were always intended for use on civilians as weapons of mass destruction.

Karen Kingston

Jun 6, 2023
June 6, 2023: Brain-computer interface (BCI) technologies connect the human brain to electronic devices and the internet by literally rewiring the brain with electrodes that are thinner than a strand of human hair.

While there was some news covering the dangers and ethics of merging the human brain with Neuralink’s brain-computer interface (BCI) technology platform last week, there was no mention that Neuralink’s FDA clearance was based on brain-computer interface (BCI) technologies that were developed as weapons of mass destruction; or who privately funded these BCI technologies.

WARNING : This information can blow-up multiple, trillion-dollar ‘healthcare’ industries. Very few alternative media outlets are willing to address these topics because as the 5th generation warfare expression goes, “The best way to defeat your opposition is to control it.

Blackrock Neurotech, based in Salt Lake City.

Utah is also the State where a school district banned The Bible for younger students:

EXCLUSIVE: This Utah biotech company has implanted brain chips in more than 30 people — and its founder wants to treat blindness, paralysis and DEPRESSION

It sounds like the stuff of science fiction - but a company in Utah has already implanted brain chips in dozens of patients.

Blackrock Neurotech, based in Salt Lake City, has the grand ambition of treating physical paralysis, blindness, deafness and depression.

The chip — known as NeuroPort Array — allow people to control robotic arms and wheelchairs, play video games and even feel sensations.

It works by using nearly 100 microneedles that attach to the brain and read electrical signals produced by someone's thoughts. More than three dozen people have so far received it.

The device was first implanted in a human in 2004. Company leaders hope to bring it to market soon, announcing in 2021 they aimed for the next year.


1 Like